MA43405A - Synthèse diastéréosélective de dérivés de phosphate et du promédicament de gemcitabine nuc-1031 - Google Patents

Synthèse diastéréosélective de dérivés de phosphate et du promédicament de gemcitabine nuc-1031

Info

Publication number: MA43405A
Authority: MA; Morocco
Prior art keywords: diasteroselective; nuc; gemcitabine; phosphate derivatives; phosphate
Prior art date: 2015-12-11

Application number

MA043405A

Other languages

English (en)

Other versions

MA43405B1 (fr

Inventor

Venkata Lakshmi Narasimha Rao Dammalapati

Mani Bushan Kotala

Original Assignee

Laurus Labs Ltd

NuCana plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-12-11

Filing date

2016-12-09

Publication date

2021-03-17

2016-02-08 Priority claimed from GBGB1602185.9A external-priority patent/GB201602185D0/en

2016-12-09 Application filed by Laurus Labs Ltd, NuCana plc filed Critical Laurus Labs Ltd

2021-03-17 Publication of MA43405A publication Critical patent/MA43405A/fr

2021-11-30 Publication of MA43405B1 publication Critical patent/MA43405B1/fr

Links

NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 title 1
NHTKGYOMICWFQZ-BBOXMAMFSA-N fosgemcitabine palabenamide Chemical compound C[C@H](N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(N)=NC2=O)C(F)(F)[C@@H]1O)OC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1 NHTKGYOMICWFQZ-BBOXMAMFSA-N 0.000 title 1
SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 title 1
229960005277 gemcitabine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/02—Phosphorylation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/222—Amides of phosphoric acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

MA43405A 2015-12-11 2016-12-09 Syntheses diastereoselectives de dérivés phosphates et du promedicament de gemcitabine nuc-1031 MA43405B1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IN6635CH2015		2015-12-11
GBGB1602185.9A GB201602185D0 (en)	2016-02-08	2016-02-08	Diastereoselective synthesis of phosphate derivatives
PCT/GB2016/053875 WO2017098252A1 (fr)	2015-12-11	2016-12-09	Synthèse diastéréosélective de dérivés de phosphate et du promédicament de gemcitabine nuc-1031

Publications (2)

Publication Number	Publication Date
MA43405A true MA43405A (fr)	2021-03-17
MA43405B1 MA43405B1 (fr)	2021-11-30

Family

ID=57570086

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA43405A MA43405B1 (fr)	2015-12-11	2016-12-09	Syntheses diastereoselectives de dérivés phosphates et du promedicament de gemcitabine nuc-1031

Country Status (29)

Country	Link
US (2)	US10774104B2 (fr)
EP (2)	EP3386998B1 (fr)
JP (1)	JP6889180B2 (fr)
KR (1)	KR20180101370A (fr)
CN (2)	CN108779136B (fr)
AU (1)	AU2016367237B2 (fr)
BR (1)	BR112018011695A2 (fr)
CA (1)	CA3007347C (fr)
CL (1)	CL2018001541A1 (fr)
CY (1)	CY1124809T1 (fr)
EA (1)	EA038658B1 (fr)
ES (1)	ES2898890T3 (fr)
HR (1)	HRP20211812T1 (fr)
HU (1)	HUE059026T2 (fr)
IL (1)	IL259887B (fr)
LT (1)	LT3386998T (fr)
MA (1)	MA43405B1 (fr)
MD (1)	MD3386998T2 (fr)
MX (1)	MX386478B (fr)
MY (1)	MY196772A (fr)
PH (1)	PH12018501224A1 (fr)
PL (1)	PL3386998T3 (fr)
PT (1)	PT3386998T (fr)
RS (1)	RS62593B1 (fr)
SA (1)	SA518391776B1 (fr)
SG (1)	SG11201804774YA (fr)
SI (1)	SI3386998T1 (fr)
SM (1)	SMT202100665T1 (fr)
WO (1)	WO2017098252A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0317009D0 (en)	2003-07-21	2003-08-27	Univ Cardiff	Chemical compounds
HUE044605T2 (hu)	2012-11-16	2019-11-28	Univ College Cardiff Consultants Ltd	RP/SP gemcitabin-[fenil-(benziloxi-L-alaninil)]-foszfát keveréke
KR102563040B1 (ko)	2014-06-25	2023-08-02	뉴카나 피엘씨	젬시타빈 전구 약물
PT3119794T (pt)	2014-06-25	2018-01-15	Nucana Biomed Ltd	Formulação que compreende um pró-fármaco de gemcitabina
GB201417644D0 (en)	2014-10-06	2014-11-19	Nucana Biomed Ltd	Method of separating phosphate diastereoisomers
CA2994502C (fr)	2015-10-05	2023-08-01	NuCana plc	Therapie combinee comprenant nuc-1031 et carboplatine pour le traitement du cancer
SMT202100665T1 (it)	2015-12-11	2022-03-21	NuCana plc	Sintesi diastereoselettiva di derivati di fosfato e del profarmaco di gemcitabina nuc-1031
GB201522771D0 (en)	2015-12-23	2016-02-03	Nucana Biomed Ltd	Crystalline form of a phosphate derivative
GB201709471D0 (en)	2017-06-14	2017-07-26	Nucana Biomed Ltd	Diastereoselective synthesis of hosphate derivatives
CN114644651A (zh) *	2022-04-13	2022-06-21	中国人民解放军军事科学院军事医学研究院	芳氧基磷酰化氨基酸酯化合物的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4526988A (en)	1983-03-10	1985-07-02	Eli Lilly And Company	Difluoro antivirals and intermediate therefor
GB0317009D0 (en)	2003-07-21	2003-08-27	Univ Cardiff	Chemical compounds
TWI583692B (zh) *	2009-05-20	2017-05-21	基利法瑪席特有限責任公司	核苷磷醯胺
US8618076B2 (en) *	2009-05-20	2013-12-31	Gilead Pharmasset Llc	Nucleoside phosphoramidates
CL2011000716A1 (es) *	2010-03-31	2012-04-20	Gilead Pharmasset Llc	Formas cristalinas 1 6 de (s)-isopropil-2-(((s)-(((2r.3r.4r.5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-4-fluoro-3-hidroxi-4-metil tetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato; composicion y combinacion farmaceutica; y su uso para tratar una infeccion por el virus de la hepatitis c.
EA025311B1 (ru)	2010-07-19	2016-12-30	Гайлид Сайэнсиз, Инк.	Способы получения диастереомерно чистых фосфорамидатных пролекарств
WO2012075140A1 (fr)	2010-11-30	2012-06-07	Pharmasset, Inc.	Composés
US20130143835A1 (en) *	2011-12-05	2013-06-06	Medivir Ab	HCV Polymerase Inhibitors
WO2013187978A1 (fr)	2012-06-16	2013-12-19	Nanjing Molecular Research, Inc.	Promédicaments de phosphoramidate et phosphonoamidate à double ciblage hépatique
HUE044605T2 (hu)	2012-11-16	2019-11-28	Univ College Cardiff Consultants Ltd	RP/SP gemcitabin-[fenil-(benziloxi-L-alaninil)]-foszfát keveréke
KR102563040B1 (ko)	2014-06-25	2023-08-02	뉴카나 피엘씨	젬시타빈 전구 약물
PT3119794T (pt)	2014-06-25	2018-01-15	Nucana Biomed Ltd	Formulação que compreende um pró-fármaco de gemcitabina
JP6646663B2 (ja)	2014-07-22	2020-02-14	ニューカナバイオメッドリミテッドＮｕｃａｎａＢｉｏｍｅｄＬｉｍｉｔｅｄ	ゲムシタビン−［フェニル（ベンゾキシ−ｌ−アラニニル）］ホスフェートの製造方法リン酸誘導体を製造する方法
KR102396905B1 (ko)	2014-08-25	2022-05-13	메디비르 아베	암 치료를 위한 우리딘의 디옥솔란 유사체
GB201417644D0 (en)	2014-10-06	2014-11-19	Nucana Biomed Ltd	Method of separating phosphate diastereoisomers
KR20180021697A (ko)	2015-05-14	2018-03-05	뉴카나 피엘씨	암 치료
CN106478753A (zh) *	2015-09-16	2017-03-08	博瑞生物医药（苏州）股份有限公司	一种nuc‑1031单一异构体的制备方法和用途
CN106543220A (zh)	2015-09-16	2017-03-29	博瑞生物医药（苏州）股份有限公司	氨基磷酸酯化合物及其制备方法和晶体
CN106543252A (zh)	2015-09-16	2017-03-29	博瑞生物医药（苏州）股份有限公司	核苷氨基磷酸酯类前药的制备方法及其中间体
CA2994502C (fr)	2015-10-05	2023-08-01	NuCana plc	Therapie combinee comprenant nuc-1031 et carboplatine pour le traitement du cancer
SMT202100665T1 (it)	2015-12-11	2022-03-21	NuCana plc	Sintesi diastereoselettiva di derivati di fosfato e del profarmaco di gemcitabina nuc-1031
GB201522771D0 (en)	2015-12-23	2016-02-03	Nucana Biomed Ltd	Crystalline form of a phosphate derivative
AU2016375861B2 (en)	2015-12-23	2021-12-23	NuCana plc	Combination therapy
WO2017109444A1 (fr)	2015-12-23	2017-06-29	Nucana Biomed Limited	Traitement combiné
GB201709471D0 (en)	2017-06-14	2017-07-26	Nucana Biomed Ltd	Diastereoselective synthesis of hosphate derivatives

2016
- 2016-12-09 SM SM20210665T patent/SMT202100665T1/it unknown
- 2016-12-09 CN CN201680081573.9A patent/CN108779136B/zh not_active Expired - Fee Related
- 2016-12-09 LT LTEPPCT/GB2016/053875T patent/LT3386998T/lt unknown
- 2016-12-09 MA MA43405A patent/MA43405B1/fr unknown
- 2016-12-09 EP EP16812797.5A patent/EP3386998B1/fr active Active
- 2016-12-09 BR BR112018011695A patent/BR112018011695A2/pt not_active Application Discontinuation
- 2016-12-09 AU AU2016367237A patent/AU2016367237B2/en not_active Ceased
- 2016-12-09 MY MYPI2018000876A patent/MY196772A/en unknown
- 2016-12-09 KR KR1020187019265A patent/KR20180101370A/ko not_active Ceased
- 2016-12-09 CA CA3007347A patent/CA3007347C/fr active Active
- 2016-12-09 MD MDE20180977T patent/MD3386998T2/ro not_active IP Right Cessation
- 2016-12-09 JP JP2018549633A patent/JP6889180B2/ja not_active Expired - Fee Related
- 2016-12-09 SI SI201631407T patent/SI3386998T1/sl unknown
- 2016-12-09 PT PT168127975T patent/PT3386998T/pt unknown
- 2016-12-09 EA EA201891391A patent/EA038658B1/ru unknown
- 2016-12-09 ES ES16812797T patent/ES2898890T3/es active Active
- 2016-12-09 RS RS20211436A patent/RS62593B1/sr unknown
- 2016-12-09 PL PL16812797T patent/PL3386998T3/pl unknown
- 2016-12-09 HU HUE16812797A patent/HUE059026T2/hu unknown
- 2016-12-09 MX MX2018007083A patent/MX386478B/es unknown
- 2016-12-09 US US16/060,681 patent/US10774104B2/en not_active Expired - Fee Related
- 2016-12-09 WO PCT/GB2016/053875 patent/WO2017098252A1/fr not_active Ceased
- 2016-12-09 CN CN202210687635.8A patent/CN115746073A/zh active Pending
- 2016-12-09 EP EP21207088.2A patent/EP4011896A1/fr not_active Withdrawn
- 2016-12-09 HR HRP20211812TT patent/HRP20211812T1/hr unknown
- 2016-12-09 SG SG11201804774YA patent/SG11201804774YA/en unknown
2018
- 2018-06-07 PH PH12018501224A patent/PH12018501224A1/en unknown
- 2018-06-07 IL IL259887A patent/IL259887B/en active IP Right Grant
- 2018-06-08 CL CL2018001541A patent/CL2018001541A1/es unknown
- 2018-06-11 SA SA518391776A patent/SA518391776B1/ar unknown
2020
- 2020-08-12 US US16/991,765 patent/US11603382B2/en active Active
2021
- 2021-11-22 CY CY20211101009T patent/CY1124809T1/el unknown

Also Published As

Publication number	Publication date
MA43405B1 (fr)	2021-11-30
CA3007347C (fr)	2020-08-04
HUE059026T2 (hu)	2022-10-28
MY196772A (en)	2023-05-03
PL3386998T3 (pl)	2022-02-07
JP2019500420A (ja)	2019-01-10
CL2018001541A1 (es)	2019-02-01
CA3007347A1 (fr)	2017-06-15
MX2018007083A (es)	2019-02-20
CN108779136B (zh)	2022-07-08
MX386478B (es)	2025-03-18
HRP20211812T1 (hr)	2022-03-04
IL259887B (en)	2020-09-30
EP3386998A1 (fr)	2018-10-17
SI3386998T1 (sl)	2022-02-28
WO2017098252A1 (fr)	2017-06-15
US11603382B2 (en)	2023-03-14
EA038658B1 (ru)	2021-09-30
CN108779136A (zh)	2018-11-09
LT3386998T (lt)	2022-01-25
SA518391776B1 (ar)	2022-01-13
MD3386998T2 (ro)	2022-03-31
US20180362571A1 (en)	2018-12-20
IL259887A (en)	2018-07-31
US10774104B2 (en)	2020-09-15
US20210009625A1 (en)	2021-01-14
PT3386998T (pt)	2021-11-30
RS62593B1 (sr)	2021-12-31
AU2016367237A1 (en)	2018-07-05
BR112018011695A2 (pt)	2018-11-27
AU2016367237B2 (en)	2020-12-24
SMT202100665T1 (it)	2022-03-21
CN115746073A (zh)	2023-03-07
JP6889180B2 (ja)	2021-06-18
EA201891391A1 (ru)	2019-02-28
EP4011896A1 (fr)	2022-06-15
SG11201804774YA (en)	2018-07-30
ES2898890T3 (es)	2022-03-09
KR20180101370A (ko)	2018-09-12
PH12018501224A1 (en)	2019-01-28
CY1124809T1 (el)	2022-11-25
EP3386998B1 (fr)	2021-11-10

Publication	Publication Date	Title
PL3507418T3 (pl)	2025-11-12	Sposoby biopochodnej derywatyzacji powierzchni celulozowych
PT3368534T (pt)	2021-03-09	Ditosilato de valbenazina e polimorfos do mesmo
PT3548033T (pt)	2024-08-09	Compostos e respectivos métodos de utilização
LT3302565T (lt)	2019-12-27	Kietos palbociklibo dozavimo formos
EP3323070A4 (fr)	2019-03-13	Analyse de néoantigènes
BR112018000129A2 (pt)	2018-09-04	oxiesteróis e seus métodos de utilização
EP3509581A4 (fr)	2020-04-08	Formulations de (r
EP3386590A4 (fr)	2019-10-16	Inhibiteurs bicycliques de pad4
MA41997A (fr)	2021-03-31	Combinaisons de cannabinoïdes et de n-acyléthanolamines
PT3645518T (pt)	2021-08-23	Síntese de omecamtiv mecarbil
PT3457851T (pt)	2021-09-28	Derivados de sobetiroma
EP3386505A4 (fr)	2019-06-26	Inhibiteurs aza-benzimidazoles de pad4
EP3356447A4 (fr)	2019-06-12	Inhibiteurs de la biosynthèse de la ménaquinone
EP3654987A4 (fr)	2021-04-28	Utilisation de dérivés aminoalkylbenzothiazépine
EP3406336A4 (fr)	2019-07-10	Nanofeuille de type structure c ur-écorce
EP3360010A4 (fr)	2019-06-19	Source accordable de bi-photons
EP3450433A4 (fr)	2019-10-16	Dérivé substitué de purine
MA43405B1 (fr)	2021-11-30	Syntheses diastereoselectives de dérivés phosphates et du promedicament de gemcitabine nuc-1031
EP3367820A4 (fr)	2019-07-10	Préparation de cellulose modifiée et ses dérivés
IL313083A (en)	2024-07-01	Terlipressin compositions and their methods of use
FR3023290B1 (fr)	2016-08-19	Derives de flavaglines
EP3328991A4 (fr)	2019-04-10	Biosynthèse de polycétides
EP3686204A4 (fr)	2021-05-19	Dérivés de thiénodiazépine et leur application
EP3526215A4 (fr)	2020-05-27	Dérivés de n-acyléthanolamide et leurs utilisations
EP3630154A4 (fr)	2021-03-10	Dérivés clivables de lipo-glycopeptides et leurs utilisations